Open access · OA
via OpenAlex
A view on drug resistance in cancer
Neil Vasan, José Baselga, David M. Hyman
Nature · 2019 · ▲ 2,695 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41586-019-1730-1
- Canonical
- link ↗
- Fetched
- 2026-06-04 MST
Cite this
APA
Vasan, N., Baselga, J., & Hyman, D.M. (2019). A view on drug resistance in cancer. <em>Nature</em>. https://doi.org/10.1038/s41586-019-1730-1
Vancouver
Vasan N, Baselga J, Hyman DM. A view on drug resistance in cancer. Nature. 2019. doi:10.1038/s41586-019-1730-1.
BibTeX
@article{neil2019Aviewo,
title = {A view on drug resistance in cancer},
author = {Neil Vasan and José Baselga and David M. Hyman},
journal = {Nature},
year = {2019},
doi = {10.1038/s41586-019-1730-1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature 2009
Open access · OA
The cancer genome
International Journal of Molecular Sciences 2017
Open access · CC-BY
Melatonin and Hippo Pathway: Is There Existing Cross-Talk?
Journal of Hematology & Oncology 2022
Open access · OA
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
Expert Opinion on Pharmacotherapy 2021
Preprint · OA
Development of the PARP inhibitor talazoparib for the treatment of advanced<i>BRCA1</i>and<i>BRCA2</i>mutated breast cancer
Frontiers in Cell and Developmental Biology 2021
Open access · CC-BY
TGF-β Signaling and Resistance to Cancer Therapy
Cell Death Discovery 2020
Open access · CC-BY